acitretin has been researched along with Carcinoma, Basal Cell in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 5 (26.32) | 2.80 |
| Authors | Studies |
|---|---|
| Farah, J; Farah, R; Weingarten, M | 1 |
| Badri, O; Karia, PS; Ruiz, ES; Schmults, CD | 1 |
| Oh, CC; Sultana, R; Tam, SYC; Tee, LY | 1 |
| Landow, SM; Lim, RK; Weinstock, MA | 1 |
| Arzeno, J; Kim, J; Leavitt, E; Lonowski, S | 1 |
| Kaffenberger, BH; Tian, F; Vaynshtok, PM | 1 |
| Baniandrés-Rodríguez, O; Conde-Montero, E; Horcajada-Reales, C; Parra-Blanco, V; Suárez-Fernández, R | 1 |
| Chong, AH; Cumming, S; Leung, V; Ng, JC | 1 |
| Konda, S; O'Bryan, KW; Patel, VA; Ratner, D | 1 |
| Chen, Z; Wu, JH; Zhang, X; Zhao, J | 1 |
| Caglia, M; Hashemi, P; Kim, C; Shulman, K | 1 |
| Aguayo, R; Baradad, M; Casanova, JM; Sanmartín, V | 1 |
| Alberts, SR; Barton, DL; Diekmann, BB; Kadakia, KC; Limburg, PJ; Loprinzi, CL; Novotny, PJ; Otley, CC; Pittelkow, MR; Sloan, JA | 1 |
| Dellavalle, R; Francis, SO; Gamble, RG; Mason, MN; Prado, R; Wing, G | 1 |
| Bannister, KM; George, R; Mathew, TH; Russ, GR; Weightman, W | 1 |
| Difonzo, EM; Giannotti, B; Pimpinelli, N; Vanzi, L | 1 |
| Ingves, C; Jemec, GB | 1 |
| Atkins, CL; Brown, VL; Cerio, R; Ghali, L; Harwood, CA; Proby, CM | 1 |
| Bavinck, JN; Hermans, J; Tegzess, AM; ter Schegget, J; Tieben, LM; Van der Woude, FJ; Vermeer, BJ | 1 |
4 review(s) available for acitretin and Carcinoma, Basal Cell
| Article | Year |
|---|---|
Efficacy and Cost Analysis for Acitretin for Basal and Squamous Cell Carcinoma Prophylaxis in Renal Transplant Recipients.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Costs and Cost Analysis; Humans; Keratolytic Agents; Kidney Transplantation; Skin Neoplasms; Transplant Recipients | 2021 |
Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Keratosis, Actinic; Niacinamide; Organ Transplantation; Randomized Controlled Trials as Topic; Skin Neoplasms; Transplant Recipients; Treatment Outcome | 2021 |
Nonmelanoma skin cancer chemoprevention.
Topics: Acitretin; Aminolevulinic Acid; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Deoxyribonuclease (Pyrimidine Dimer); Eflornithine; Humans; Monoterpenes; Peroxisome Proliferator-Activated Receptors; Photochemotherapy; Photosensitizing Agents; Polyphenols; Retinoids; Skin Neoplasms; Viral Proteins | 2011 |
Combined imiquimod and acitretin for non-surgical treatment of basal cell carcinoma.
Topics: Acitretin; Algorithms; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Drug Synergism; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; Treatment Outcome | 2003 |
4 trial(s) available for acitretin and Carcinoma, Basal Cell
| Article | Year |
|---|---|
Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251).
Topics: Acitretin; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms, Second Primary; Placebos; Retinoids; Risk; Skin Neoplasms; Time Factors | 2012 |
Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients.
Topics: Acitretin; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cross-Over Studies; Female; Humans; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Skin Neoplasms | 2002 |
Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
Topics: Acitretin; Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind Method; Female; Humans; Imiquimod; Immunosuppression Therapy; Keratolytic Agents; Kidney Transplantation; Male; Middle Aged; Ointments; Precancerous Conditions; Risk Factors; Skin; Skin Neoplasms | 2005 |
Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study.
Topics: Acitretin; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chi-Square Distribution; Double-Blind Method; Female; Humans; Keratosis; Kidney Transplantation; Male; Middle Aged; Skin Neoplasms | 1995 |
11 other study(ies) available for acitretin and Carcinoma, Basal Cell
| Article | Year |
|---|---|
Treatment of Reactive Keratoacanthomas with Acitretin Following Multiple Excisions and Mohs Surgery for Recurrent Squamous Cell Carcinoma.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Keratoacanthoma; Mohs Surgery; Neoplasm Recurrence, Local; Skin Neoplasms | 2022 |
Acitretin for Secondary Prevention of Keratinocyte Cancers in a Veteran Population: A Retrospective Cohort Study.
Topics: Acitretin; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Drug Prescriptions; Female; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Neoplasm Recurrence, Local; Retrospective Studies; Secondary Prevention; Skin; Skin Neoplasms; Veterans | 2021 |
Current Practices for Preventative Interventions for Nonmelanoma Skin Cancers Among Dermatologic Surgeons.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatologic Agents; Humans; Institutional Practice; Keratosis, Actinic; Mohs Surgery; Niacinamide; Practice Patterns, Physicians'; Private Practice; Skin Neoplasms; Surveys and Questionnaires; Vitamin B Complex | 2021 |
Acitretin amelioration of Acrokeratosis Paraneoplastica (Bazex Syndrome) in cases of incurable squamous cell carcinoma of the hypopharynx.
Topics: Acitretin; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Hypotrichosis; Keratolytic Agents; Male; Middle Aged; Paraneoplastic Syndromes; Skin Diseases; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2016 |
Paraneoplastic acrokeratosis (Bazex syndrome): unusual association with in situ follicular lymphoma and response to acitretin.
Topics: Acitretin; Carcinoma, Basal Cell; Diagnosis, Differential; Female; Foot; Hand; Humans; Hypotrichosis; Keratolytic Agents; Lymphoma, Follicular; Middle Aged; Skin Neoplasms | 2017 |
Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
Topics: Acitretin; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Immunosuppression Therapy; Keratolytic Agents; Kidney Transplantation; Male; Middle Aged; Occupational Exposure; Prospective Studies; Skin Neoplasms; Sunlight; Tertiary Care Centers; Victoria | 2014 |
Fibrohistiocytic tumors in a lung transplant patient taking oral capecitabine for nonmelanoma skin cancer chemoprevention.
Topics: Acitretin; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Deoxycytidine; Fatal Outcome; Fluorouracil; Graft vs Host Disease; Head and Neck Neoplasms; Histiocytoma, Malignant Fibrous; Humans; Keratolytic Agents; Lung Transplantation; Male; Skin Neoplasms | 2014 |
Case Report: Bazex Syndrome Associated With Pulmonary Adenocarcinoma.
Topics: Acitretin; Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Biopsy, Needle; Bone Neoplasms; Carcinoma, Basal Cell; Dexamethasone; Drug Therapy, Combination; Follow-Up Studies; Gefitinib; Humans; Hypotrichosis; Immunohistochemistry; Lung Neoplasms; Lymph Nodes; Male; Paraneoplastic Syndromes; Quinazolines; Radiography; Rare Diseases; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2016 |
Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate.
Topics: Acitretin; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Drug Resistance; Epidermodysplasia Verruciformis; Female; Gels; Humans; Imiquimod; Keratolytic Agents; Rare Diseases; Skin Neoplasms; Treatment Outcome; Tretinoin | 2016 |
[Oral acitretin and topical imiquimod as neoadjuvant treatment for giant basal cell carcinoma].
Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Aged; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Combined Modality Therapy; Facial Neoplasms; Female; Humans; Imiquimod; Neoadjuvant Therapy; Psoriasis; Remission Induction; Skin Neoplasms; Skin Ulcer; Thoracic Neoplasms | 2012 |
The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin.
Topics: Acitretin; Administration, Oral; Administration, Topical; Adolescent; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Therapy, Combination; Facial Neoplasms; Humans; Imiquimod; Keratolytic Agents; Male; Treatment Outcome; Xeroderma Pigmentosum | 2003 |